Completed PHASE3 INTERVENTIONAL 2-arm NCT01297465

PERgoveriS In Stratified Treatment for Assisted Reproductive Technique (PERSIST)

A Phase IIIB, Multicentre, Multinational, Randomized, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® Day 1 to Day 5 Followed by Pergoveris® Starting Day 6 to Pergoveris® Starting Day 1 in Women Between 36 and 40 Years of Age Undergoing Assisted Reproductive Technique (ART)

Sponsor: LLC Merck, Russia

Conditions Assisted Reproductive Techniques Reproductive Technology, Assisted

Interventions Gonal-f® Pergoveris® Recombinant human chorionic gonadotropin (r-hCG)

Updated 8 times since 2017 Last updated: May 4, 2021 Started: May 31, 2011 Primary completion: Oct 31, 2012 Completion: Oct 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Assisted Reproductive Techniques and Reproductive Technology, Assisted, this trial is completed. The trial is conducted by LLC Merck, Russia and has accumulated 8 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jun 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Jun 2021 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jan 2019 — Jan 2021 [monthly]

Completed PHASE3
Jun 2018 — Jan 2019 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

LLC Merck, Russia
Merck A.E., Greece
Merck A/S, Denmark
Merck B.V., Netherlands
Merck KGaA, Darmstadt, Germany
Merck OY, Finland
Merck Pharma, K.S., Slovakia
Merck SP. Z.O.O., Poland
Merck Serono GmbH, Germany
Merck Serono S.A., Geneva
Merck Serono S.A.S, France
Merck Serono S.P.A., Italy
Merck Services U.K. Ltd, UK
Merck spol. s r.o., Slovakia

Data source: Merck KGaA, Darmstadt, Germany

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Athens, Greece , Berlin, Germany , Bologna, Italy , Bondy, France , Bratislava, Slovakia , Bruges, France , Clamart, France , Dronninglund, Denmark , Florence, Italy , Fredericia, Denmark and 13 more locations